Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease

D. W. Chan, M. J. Bill, N. Rosenshein

Research output: Contribution to journalArticlepeer-review

Abstract

Human chorionic gonadotrophin (hCG) is present in high concentration in patients with trophoblastic disease. The hCG concentration parallels tumor activity. The first known case of an endogenous binder for hCG in the serum of a patient with trophoblastic disease is reported. The patient's hCG concentration was not detectable when analyzed by a radioimmunoassay using a double antibody method; however, it was positive by a radioimmunoassay using polyethylene glycol precipitation. A high serum blank was also observed in this patient. This led the authors to suspect the presence of an endogenous binder for hCG. Scatchard analysis of the patient's serum revealed a high affinity binder for hCG with Ka = 2 X 1011 M-1, concentration of binding site = 7 X 10-12 M, and a lower affinity binder with Ka = 1 X 1010 M-1, concentration of binding site = 2 X 10-11 M. This investigation strongly suggested a specific binder(s) for hCG in the serum of this patient.

Original languageEnglish (US)
Pages (from-to)214-216
Number of pages3
JournalAmerican journal of clinical pathology
Volume76
Issue number2
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease'. Together they form a unique fingerprint.

Cite this